healthneutral
Blood Tests and Big Dreams: The New Venture of Elizabeth Holmes' Partner
USASunday, May 11, 2025
Haemanthus plans to start with pets. This might be a smart move. It is easier to test new ideas on pets first. Then, they can move to humans. The company wants to raise over $50 million. This is a lot of money. It shows they are serious. But, it also shows they need a lot of support.
Some investors are cautious. Jim Breyer is one of them. He invested in Facebook early on. He was asked to invest in Haemanthus. He said no. He had the same concerns as when he passed on Theranos. This is a red flag. It shows that some people are worried. They do not want to make the same mistakes again.
Holmes is still hopeful. She said she wants to make healthcare affordable for everyone. This is a noble goal. But, actions speak louder than words. It is important to see results. Not just promises. The world is watching. They want to see if Haemanthus can deliver. Or if it will be another failed dream.
Actions
flag content